Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

280 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Ticagrelor vs Prasugrel for Acute Coronary Syndrome in Routine Care.
Krüger N, Krefting J, Kessler T, Schmieder R, Starnecker F, Dutsch A, Graesser C, Meyer-Lindemann U, Storz T, Pugach I, Frieß C, Chen Z, Bongiovanni D, Manea I, Dreischulte T, Offenborn F, Krase P, Sager HB, Wiebe J, Kufner S, Xhepa E, Joner M, Trenkwalder T, Gueldener U, Kastrati A, Cassese S, Schunkert H, von Scheidt M; DigiMed Bayern Consortium. Krüger N, et al. JAMA Netw Open. 2024 Dec 2;7(12):e2448389. doi: 10.1001/jamanetworkopen.2024.48389. JAMA Netw Open. 2024. PMID: 39621344 Free PMC article.
LINE-1 cfDNA Methylation as an Emerging Biomarker in Solid Cancers.
Gezer U, Özgür E, Yörüker EE, Polatoglou E, Holdenrieder S, Bronkhorst A. Gezer U, et al. Among authors: holdenrieder s. Cancers (Basel). 2024 Nov 5;16(22):3725. doi: 10.3390/cancers16223725. Cancers (Basel). 2024. PMID: 39594682 Free PMC article. Review.
Recurrent depression predicts high leptin concentrations in patients with coronary artery disease over an 18-months follow-up period: Findings from the prospective multicenter randomized controlled SPIRR-CAD Trial.
Ladwig KH, Marten-Mittag B, Olliges E, Johar H, Atasoy S, Holdenrieder S, Albus C, Deter HC, DeZwaan M, Fritzsche K, Jünger J, Petrowski K, Michal M, Söllner W, Weber CS, Herrmann-Lingen C, Ronel J. Ladwig KH, et al. Among authors: holdenrieder s. J Affect Disord. 2025 Jan 15;369:174-181. doi: 10.1016/j.jad.2024.09.146. Epub 2024 Sep 24. J Affect Disord. 2025. PMID: 39321975 Free article. Clinical Trial.
External quality assessment-based tumor marker harmonization simulation; insights in achievable harmonization for CA 15-3 and CEA.
Van Rossum HH, Holdenrieder S, Yun YM, Patel D, Thelen M, Song J, Unsworth N, Partridge K, Moore M, Cui W, Ramanathan L, Meng QH, Ballieux BEPB, Sturgeon C, Vesper H. Van Rossum HH, et al. Among authors: holdenrieder s. Clin Chem Lab Med. 2024 Sep 20. doi: 10.1515/cclm-2024-0696. Online ahead of print. Clin Chem Lab Med. 2024. PMID: 39299928
Moving Forward on Tumor Pathology Research Reporting: A Guide for Pathologists From the World Health Organization Classification of Tumors Living Evidence Gap Map by Tumour Type Group.
Colling R, Indave I, Del Aguilla J, Cierco Jimenez R, Campbell F, Chechlinska M, Kowalewska M, Holdenrieder S, Trulson I, Worf K, Pollán M, Plans-Beriso E, Pérez-Gómez B, Craciun O, García-Ovejero E, Michalek IM, Maslova K, Rymkiewicz G, Didkowska J, Tan PH, Diyana Bte Md Nasir N, Myles N, Giesen C, Goldman-Lévy G, Lokuhetty D, Cree IA. Colling R, et al. Among authors: holdenrieder s. Mod Pathol. 2024 Jul;37(7):100515. doi: 10.1016/j.modpat.2024.100515. Epub 2024 May 17. Mod Pathol. 2024. PMID: 38763419 Free article. Review.
[Personalized diagnostics for GI tumors: Which is useful?].
Heiliger C, Heinrich K, Holdenrieder S, Cyran C, Jacob S, Angele M. Heiliger C, et al. Among authors: holdenrieder s. MMW Fortschr Med. 2024 Apr;166(6):50-55. doi: 10.1007/s15006-024-3726-5. MMW Fortschr Med. 2024. PMID: 38581517 Review. German. No abstract available.
280 results